Skip to main content
SpringerLink
Log in

Immune checkpoint inhibitors may increase risk of AKI

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Single and combination immunotherapy with chemotherapy and the risk of AKI in patients with solid cancer Clinical and Experimental Nephrology : 23 Nov 2023. Available from: URL: https://doi.org/10.1007/s10157-023-02429-8

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Immune checkpoint inhibitors may increase risk of AKI. Reactions Weekly 1985, 11 (2023). https://doi.org/10.1007/s40278-023-50781-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-50781-9

Search

Navigation